Skip to main content
UniHealth

Doctor search

Sophie Laurel Karen Mintz, NP

Nurse Practitioner · Stanford

NPI 1164720546

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
12 years
Graduated 2014

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sophie Laurel Karen Mintz’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$8,056

Medicare paid this office $8,056 for 57 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)19$2,671$141
Return visit (30+ min)18$2,110$106

Procedures Medicare counted

Procedure volume Medicare published
Hernia repair (minimally invasive)1-10None

Who their Medicare patients are

57 Original Medicare patients in 2024. Average age 60 · Under 65 56% · Women 75% · Also on Medicaid 67% · Health risk score 1.54. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Diabetes 42% · Depression 37% · Heart failure 30% · Chronic kidney disease 23% · Coronary heart disease 19%.

The office billed $68,024, Medicare allowed $10,527 and paid $8,056; for 70 services of 10 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20245770601.54$68,024$8,056
202383126631.37$93,946$9,506
202284118641.28$78,392$7,896
202179106621.62$77,900$8,531
2020100131621.80$59,588$6,521
201989121631.54$8,616$4,750
201891121611.90$9,034$4,702
20175761611.76$5,467$2,657
20161920531.28$3,140$1,201

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Long return visit (40+ min)33$3,709$98
Return visit (30+ min)34$2,988$75
Short return visit (20+ min)25$1,348$43

2022: 3 services

Original Medicare services billed in 2022
Return visit (30+ min)34$2,667$67
Long return visit (40+ min)22$2,174$95
Short return visit (20+ min)26$1,197$40

2021: 3 services

Original Medicare services billed in 2021
Return visit (30+ min)21$1,700$81
Long return visit (40+ min)12$1,572$121
Short return visit (20+ min)26$1,495$48

2020: 3 services

Original Medicare services billed in 2020
Short return visit (20+ min)49$2,185$35
Extended patient service without direct patient contact, first hour20$1,871$89
Return visit (30+ min)13$815$63

2019: 1 service

Original Medicare services billed in 2019
Short return visit (20+ min)77$3,654$35

2018: 1 service

Original Medicare services billed in 2018
Short return visit (20+ min)78$3,721$35

2017: 1 service

Original Medicare services billed in 2017
Short return visit (20+ min)39$1,668$39

2016: 1 service

Original Medicare services billed in 2016
Short return visit (20+ min)11$479$44

Medicaid work

$1,470 in 2020

Medicaid paid $1,470 for 85 billed services this clinician did in 2020, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Short return visit (20+ min)85$1,470
Medicaid work by year
202085120$1,470
2019125122$3,255
2018103122$2,810
See the largest Medicaid services in earlier years

2019

Largest Medicaid services in 2019
Short return visit (20+ min)125$3,255

2018

Largest Medicaid services in 2018
Short return visit (20+ min)103$2,810

Drugs they prescribed that Part D paid

$93,844

Pharmacies billed $93,844 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

250 generic and fewer than 11 brand-name prescriptions · $93,844 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic46$54,318$1,181
Mounjaro32$30,582$956
Sucralfate22$1,587$72
Ursodiol13$747$57
Pantoprazole94$726$8
See all 10 drugs
Every Part D drug this clinician prescribed
Ozempic46$54,318$1,181
Mounjaro32$30,582$956
Sucralfate22$1,587$72
Ursodiol13$747$57
Pantoprazole94$726$8
Naltrexone15$699$47
Omeprazole11$322$29
Bupropion Hcl Sr11$300$27
Metformin20$186$9
Ondansetron Odt16$142$9

Year by year

Part D prescribing by year
202433785NoneNone$93,844
20235991123% (17)None$276,982
2022516983% (13)36%$191,133
20213331026% (21)26%$96,547
2020370863% (12)15%$92,059
20194161054% (16)18%$90,045
2018290884% (12)21%$72,733
20171797010% (17)None$26,141
20161133512% (14)None$14,578
201516None0% (0)None$1,718

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Part D drugs prescribed in 2023
Ozempic194$202,015$1,041
Mounjaro29$33,591$1,158
Trulicity19$18,358$966
Sucralfate39$7,160$184
Dexlansoprazole Dr12$2,835$236
Ursodiol21$2,422$115
Naltrexone35$1,806$52
Pantoprazole69$1,126$16
Bupropion Hcl Sr32$755$24
Omeprazole18$564$31
Topiramate35$466$13
Metformin21$464$22
Oxycodone15$237$16
Ondansetron Odt11$120$11

2022: 13 drugs

Part D drugs prescribed in 2022
Ozempic100$109,973$1,100
Trulicity29$30,256$1,043
Victoza 3-Pak17$25,732$1,514
Sucralfate32$4,599$144
Naltrexone41$1,554$38
Ursodiol12$1,178$98
Bupropion Hcl Sr37$1,154$31
Pantoprazole35$879$25
Nano 2nd Gen Pen Needle11$556$51
Metformin45$462$10
Topiramate64$416$7
Omeprazole16$347$22
Oxycodone13$340$26

2021: 10 drugs

Part D drugs prescribed in 2021
Victoza 3-Pak40$46,642$1,166
Trulicity24$20,878$870
Naltrexone33$2,097$64
Sucralfate12$1,941$162
Pantoprazole55$1,424$26
Bupropion Xl14$1,097$78
Bupropion Hcl Sr14$337$24
Oxycodone18$226$13
Metformin31$191$6
Gabapentin13$126$10

2020: 6 drugs

Part D drugs prescribed in 2020
Victoza 3-Pak32$54,899$1,716
Naltrexone55$2,891$53
Pantoprazole84$1,333$16
Bupropion Xl16$1,011$63
Bupropion Hcl Sr24$622$26
Metformin44$427$10

2019: 9 drugs

Part D drugs prescribed in 2019
Victoza 3-Pak52$68,033$1,308
Naltrexone52$1,988$38
Novofine 3222$1,086$49
Pantoprazole59$769$13
Bupropion Hcl Sr34$687$20
Metformin58$354$6
Bupropion Xl11$337$31
Omeprazole13$303$23
Topiramate14$91$6

2018: 7 drugs

Part D drugs prescribed in 2018
Victoza 3-Pak45$43,199$960
Naltrexone23$714$31
Bupropion Hcl Sr22$409$19
Omeprazole18$403$22
Pantoprazole39$375$10
Ultra-Fine Nano Pen Needle12$365$30
Metformin59$317$5

2017: 5 drugs

Part D drugs prescribed in 2017
Victoza 3-Pak15$16,096$1,073
Ursodiol14$4,187$299
Pantoprazole42$294$7
Hydrocodone-Acetaminophen12$218$18
Metformin19$130$7

2016: 4 drugs

Part D drugs prescribed in 2016
Ursodiol29$5,477$189
Enoxaparin16$3,959$247
Pantoprazole29$187$6
Oxycodone12$66$5

Money from drug and device companies

$98 in 2023

Industry payments by year
202311None$98
202211None$150

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Mirum PharmaceuticalsLivmarli$98
1 payment
  • Meals for Livmarli · 2023-06-01 · $98
See the published payment
Every published payment
Mirum PharmaceuticalsMeals · 2023-06-01Livmarli$98
See earlier years (2022)

2022: $150

Payments by company in 2022
Mirum PharmaceuticalsLivmarli$150
1 payment
  • Meals for Livmarli · 2022-12-14 · $150

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Mirum Pharmaceuticals, Inc. · A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry To Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (Replace) · 2025This clinician$3,980
Mirum Pharmaceuticals, Inc. · A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry To Collect Data on Routine Clinical Care in Patients Treated With Cholbam (Cholic Acid) (Replace) · 2024This clinician$1,300

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1164720546
Licence
AK 31784, CA 95006185, PA SP014819
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
PA 103055604
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2011-03-08
NPI last updated
2025-12-31
NPI record certified
2025-12-31

This is when the NPI record was last certified, not a medical board exam.